全文获取类型
收费全文 | 7505篇 |
免费 | 503篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 185篇 |
妇产科学 | 197篇 |
基础医学 | 937篇 |
口腔科学 | 157篇 |
临床医学 | 802篇 |
内科学 | 1435篇 |
皮肤病学 | 67篇 |
神经病学 | 722篇 |
特种医学 | 187篇 |
外科学 | 866篇 |
综合类 | 75篇 |
一般理论 | 8篇 |
预防医学 | 979篇 |
眼科学 | 300篇 |
药学 | 679篇 |
中国医学 | 3篇 |
肿瘤学 | 370篇 |
出版年
2023年 | 71篇 |
2022年 | 89篇 |
2021年 | 185篇 |
2020年 | 106篇 |
2019年 | 189篇 |
2018年 | 239篇 |
2017年 | 150篇 |
2016年 | 169篇 |
2015年 | 180篇 |
2014年 | 257篇 |
2013年 | 381篇 |
2012年 | 599篇 |
2011年 | 711篇 |
2010年 | 329篇 |
2009年 | 337篇 |
2008年 | 529篇 |
2007年 | 551篇 |
2006年 | 499篇 |
2005年 | 502篇 |
2004年 | 442篇 |
2003年 | 341篇 |
2002年 | 317篇 |
2001年 | 79篇 |
2000年 | 51篇 |
1999年 | 72篇 |
1998年 | 61篇 |
1997年 | 55篇 |
1996年 | 36篇 |
1995年 | 33篇 |
1994年 | 31篇 |
1993年 | 36篇 |
1992年 | 38篇 |
1991年 | 19篇 |
1990年 | 17篇 |
1989年 | 13篇 |
1987年 | 21篇 |
1986年 | 16篇 |
1984年 | 11篇 |
1983年 | 13篇 |
1982年 | 17篇 |
1981年 | 17篇 |
1980年 | 14篇 |
1979年 | 14篇 |
1978年 | 11篇 |
1977年 | 12篇 |
1976年 | 10篇 |
1968年 | 10篇 |
1967年 | 10篇 |
1923年 | 10篇 |
1922年 | 28篇 |
排序方式: 共有8020条查询结果,搜索用时 12 毫秒
51.
Shamsah Kazani David J. Rowlands Ivan Bottoli Julie Milojevic Jose Alcantara Ieuan Jones Kenneth Kulmatycki Surendra Machineni Lidia Mostovy Ian Nicholls Jerry A. Nick Steven M. Rowe Nicholas J. Simmonds Raju Vegesna Jeroen Verheijen Henry Danahay Martin Gosling Phaninatha Sarma Ayalavajjala Robert Strieter 《Journal of cystic fibrosis》2021,20(2):250-256
BackgroundThis is the first-in-human study of icenticaftor, an oral potentiator of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) channel. Restoration of CFTR activity has shown significant clinical benefits, but more studies are needed to address all CFTR mutations.MethodsSafety, pharmacodynamics/pharmacokinetics of icenticaftor were evaluated in a randomized, double-blind, placebo-controlled study in healthy volunteers. Efficacy was assessed in adult CF patients with ≥1 pre-specified CFTR Class III or IV mutation (150 and 450 mg bid), or homozygous for F508del mutation (450 mg bid). Primary efficacy endpoint was change from baseline in lung clearance index (LCI2.5). Secondary endpoints included %predicted FEV1 and sweat chloride level.ResultsClass IV mutations were present in 22 patients, Class III in 2 (both S549N), and 25 were homozygous for F508del. Icenticaftor was well-tolerated in healthy and CF subjects with no unexpected events or discontinuations in the CF groups. The most frequent study-drug related adverse events in CF patients were nausea (12.2%), headache (10.2%), and fatigue (6.1%). Icenticaftor 450 mg bid for 14 days showed significant improvements in all endpoints versus placebo in patients with Class III and IV mutations; mean %predicted FEV1 increased by 6.46%, LCI2.5 decreased by 1.13 points and sweat chloride decreased by 8.36 mmol/L. No significant efficacy was observed in patients homozygous for a single F508del.ConclusionsIcenticaftor was safe and well-tolerated in healthy volunteers and CF patients, and demonstrated clinically meaningful changes in lung function and sweat chloride level in CF patients with Class III and IV CFTR mutations.ClinicalTrials.gov: NCT02190604 相似文献
52.
Patricia M. Lenhart-Pendergrass Lindsay J. Caverly Brandie D. Wagner Scott D. Sagel Jerry A. Nick John J. LiPuma Stacey L. Martiniano 《Journal of cystic fibrosis》2021,20(2):310-315
BackgroundMolecular diagnostics have led to the identification of a broad range of bacterial species in cystic fibrosis (CF) including Inquilinus. The clinical significance of Inquilinus in CF has not been thoroughly characterized.MethodsRetrospective, case-control study of persons with CF from two CF centers with at least one respiratory culture positive for Inquilinus spp. compared with age-matched CF controls with chronic Pseudomonas aeruginosa. Percent predicted forced expiratory volume in one second (ppFEV1) and body mass index percentile (BMI) were modeled from time of first positive culture up to 5 years later. Rates of pulmonary exacerbations were compared. Inquilinus isolates were genotyped to evaluate strain diversity.ResultsSeventeen patients with Inquilinus infection were identified with a mean age of 13 years at first positive culture. Most cases had multiple cultures positive for Inquilinus. ppFEV1 was not different between cases versus controls (80.2% vs 81.6%, p = 0.97 at baseline, 67.5% vs. 73.3%, p = 0.82 at 5 years). Patients were undernourished and BMI percentiles did not differ between groups (30.7% vs 43.4%, p = 0.32 at baseline, 37.9% vs. 37.6%, p = 0.98 at 5 years). There was no difference in the pulmonary exacerbation rate (3.0/year vs 2.5/year, p = 0.34). Genotyping showed diverse genetic strains between patients.ConclusionsInquilinus can present in childhood and is often associated with chronic infection in CF. Lung function and nutrition status at time of detection, lung function decline, and pulmonary exacerbation rates in Inquilinus cases were similar to those with chronic P. aeruginosa, a well-established CF pathogen. 相似文献
53.
Adi Lustig Paulo Alves Evan Call Nick Santamaria Amit Gefen 《International wound journal》2021,18(2):194
Wound‐dressing performances are affected by exudate viscosity, resistance to flow because of gravity, and bodyweight loads, the level of which is related to the body position. Here, we focussed on two dressing properties: (a) Sorptivity—the ability of dressings to transfer exudate away from the wound bed by capillary action—and (b) Durability—the capacity of dressings to maintain their integrity over time and during their removal. Both properties are critically important for avoiding further tissue damage but require the development of new laboratory tests for their measurement. A computer‐controlled phantom of an exuding sacral pressure ulcer has therefore been developed and used to compare the performances of Exufiber (Mölnlycke Health Care) vs an alternative market‐leading dressing. Sorptivity was determined using weight tests, and durability was measured through tensile tests of the used dressings. For a supine configuration, the Exufiber dressing demonstrated ~three times higher sorptivity and better durability, withstanding ~five times greater strain energy than the other product before failure occurred. This work paves the way for quantitative, standardised testing of dressings in all aspects of exudate management. The reported tests are further suitable for testing dressing combinations or how dressings interact with negative pressure wound therapy. 相似文献
54.
Justin Bubola Klieb Hagen Nick Blanas Ilan Weinreb Brendan C. Dickson Tra Truong 《Head and neck pathology》2021,15(1):319
Ectomesenchymal chondromyxoid tumor is a rare neoplasm of uncertain histogenesis that typically occurs in the anterior dorsal tongue. Recent reports in the literature have described rare examples of gingival, palatal and tonsillar lesions. Histologically, ectomesenchymal chondromyxoid tumors are typically well-circumscribed, lacking overtly aggressive features. Herein we report a tumor arising in the right mandible that is morphologically and molecularly consistent with ectomesenchymal chondromyxoid tumor. This case furthers awareness of the extra-glossal distribution of this neoplasm; moreover, it suggests that a subset of these tumors have the potential for locally aggressive behaviour.Electronic supplementary materialThe online version of this article (10.1007/s12105-020-01169-5) contains supplementary material, which is available to authorized users. 相似文献
55.
56.
57.
58.
59.
60.
Eleni Petridou Freda E. Alexander Dimitrios Trichopoulos Katharine Revinthi Nick Dessypris Naomi Wray Stavros Haidas Dimitrios Koliouskas Helen Kosmidis Fani Piperopoulou Fotini Tzortzatou 《Cancer causes & control : CCC》1997,8(2):239-245
A total of 872 children aged up to 14 years, who were diagnosed withleukemia in Greece during the decade 1980-89, were allocated by place ofresidence to the 601 administrative districts of the country. Evaluation ofspatial clustering was done using the Potthoff-Whittinghill method, whichvalidly assesses heterogeneity of leukemia risk among districts with variableexpected numbers of cases. There was highly significant evidence for spatialclustering occurring particularly among children living in urban and, to alesser extent, semi-urban areas. The evidence was stronger for childrenyounger than 10 years old, applied also to children in different five-yearage groups, and persisted when cases of acute lymphoblastic leukemia wereanalyzed separately. These findings provide support to the hypothesis thatlocalized environmental exposures could contribute to the etiology ofchildhood leukemia, but they cannot distinguish between exposures of physicalor chemical nature, nor can they exclude socially conditioned patterns ofexposure to infectious agents. 相似文献